ArticleResearch in pharmaceutical sciences2025
Gold nanoparticles from
Article in Research in pharmaceutical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- IGFBP-3 enhances irinotecan efficacy in colorectal cancerResearch in pharmaceutical sciences · 2026Article
- Biosynthesis, characterization, and antiproliferative activity of gold nanoparticles synthesized using Artemisia chamaemelifolia extract against cisplatin-resistant ovarian cancer cells.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026Article
- Antibacterial and cytotoxic activity of biosynthesis gold nanoparticles using Morus nigra leaf extract.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Plant Bioactive Compounds at the Interface of Extraction Science, Green Nanoparticles and Applied Biotechnology: A Narrative Review.Molecules (Basel, Switzerland) · 2026Review
- Design, synthesis, and biological evaluation of novel aryl isoxazoles as potential Hsp90 inhibitors.Research in pharmaceutical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Metallic nanoparticles (NPs) can be applied in various biomedical fields, such as antibacterial and anti-cancer agents. Synthesizing metallic NPs by green chemistry procedures makes them eco-friendly and easier to prepare. This study aimed to develop 3 different gold (Au) NPs, using plant extracts including Experimental approach: Green AuNPs were synthesized by mixing plant extracts and HAuCl Findings/Results: AA-AuNPs, MN-AuNPs, and PH-AuNPs were cytotoxic against cancer cell lines in a dose-dependent manner. Results also revealed that PH-AuNPs were the most potent NPs (IC Conclusion and implications: Using plants to formulate metallic NPs is inexpensive, easily accessible, and renewable. Additionally, due to their considerable cytotoxicity, their applications as a cancer treatment option is a promising approach that warrants further investigation. Thus, the rapidly synthesized AuNPs can play a role in nanotechnology and biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.